FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Deborah Birx

Research Profile

Living Beings

HIV-1

Disorders

HIV Infections

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Thailand

Physiology

Recombination, Genetic

Procedures

Genes & Molecular Sequences

Phenomena

HIV Seropositivity

Anatomy

CD4-Positive T-Lymphocytes

Co-author Network

Publications

TOP 3
Josephine H Cox; Patricia Earl; Leigh Anne Eller; Guido Ferrari; Maria G Ferrari; Lydia Hart; Linda L Jagodzinski; Jerome H Kim; Ellen Kuta; James R Lane; David Montefiori; Bernard Moss; Stephanie Parrish; Doan-Trang Pham; Victoria R Polonis; Silvia Ratto-Kim; Deborah L Birx; Jean D Boyer; David B Weiner; Thomas C VanCott
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.
Steffen Geis; Christof Geldmacher; Deborah L Birx; Oliver Hoffmann; Leonard Maboko; Nelson L Michael; Donan Mmbando; Merlin L Robb; Elmar Saathoff; Eleuter Samky; Michael Hoelscher
Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, Tanzania.
Andrew Rosa Borges; Lindsay Wieczorek; Benitra Johnson; Alan J Benesi; Bruce K Brown; Richard D Kensinger; Fred C Krebs; Brian Wigdahl; Robert Blumenthal; Anu Puri; Francine E McCutchan; Deborah L Birx; Victoria R Polonis; Cara-Lynne Schengrund
Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Deborah Birx (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Josephine H Cox; Patricia Earl; Leigh Anne Eller; Guido Ferrari; Maria G Ferrari; Lydia Hart; Linda L Jagodzinski; Jerome H Kim; Ellen Kuta; James R Lane; David Montefiori; Bernard Moss; Stephanie Parrish; Doan-Trang Pham; Victoria R Polonis; Silvia Ratto-Kim; Deborah L Birx; Jean D Boyer; David B Weiner; Thomas C VanCott
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.
Vaccine 2012;30(10):1830-40.
2011: Steffen Geis; Christof Geldmacher; Deborah L Birx; Oliver Hoffmann; Leonard Maboko; Nelson L Michael; Donan Mmbando; Merlin L Robb; Elmar Saathoff; Eleuter Samky; Michael Hoelscher
Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, Tanzania.
Journal of acquired immune deficiency syndromes (1999) 2011;56(5):453-9.
2010: Andrew Rosa Borges; Lindsay Wieczorek; Benitra Johnson; Alan J Benesi; Bruce K Brown; Richard D Kensinger; Fred C Krebs; Brian Wigdahl; Robert Blumenthal; Anu Puri; Francine E McCutchan; Deborah L Birx; Victoria R Polonis; Cara-Lynne Schengrund
Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.
Virology 2010;408(1):80-8.
2010: Guy-Michel Gershy-Damet; Philip Rotz; David Cross; El Hadj Belabbes; Fatim Cham; Jean-Bosco Ndihokubwayo; Glen Fine; Clement Zeh; Patrick A Njukeng; Souleymane MBoup; Daniel E Sesse; Tsehaynesh Messele; Deborah L Birx; John N Nkengasong
The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region.
American journal of clinical pathology 2010;134(3):393-400.
2010: Douglas N Shaffer; Ignatius K Ngetich; Christian T Bautista; Frederick K Sawe; Philip O Renzullo; Paul T Scott; Rukia M Kibaya; Kennedy O Imbuki; Nelson L Michael; Deborah L Birx; Monique K Wasunna; Merlin L Robb
HIV-1 incidence rates and risk factors in agricultural workers and dependents in rural Kenya: 36-month follow-up of the Kericho HIV cohort study.
Journal of acquired immune deficiency syndromes (1999) 2010;53(4):514-21.
2010: Hannah Kibuuka; Robert Kimutai; Leonard Maboko; Fred Sawe; Mirjam S Schunk; Arne Kroidl; Douglas Shaffer; Leigh Anne Eller; Rukia Kibaya; Michael A Eller; Karin B Schindler; Alexandra Schuetz; Monica Millard; Jason Kroll; Len Dally; Michael Hoelscher; Robert Bailer; Josephine H Cox; Mary Marovich; Deborah L Birx; Barney S Graham; Nelson L Michael; Mark de Souza; Merlin L Robb
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).
The Journal of infectious diseases 2010;201(4):600-7.
2010: Jean K Carr; Nathan D Wolfe; Judith N Torimiro; Ubald Tamoufe; E Mpoudi-Ngole; Lindsay M Eyzaguirre; Deborah L Birx; Francine E McCutchan; Donald S. Burke
HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: evolutionary relics?
Retrovirology 2010;7():39.
2009: Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.
The New England journal of medicine 2009;361(23):2209-20.
2009: Miguel A Arroyo; Warren B Sateren; Ginamarie Foglia; Rukia Kibaya; Lilian Langat; Monique Wasunna; Christian T Bautista; Paul T Scott; Douglas N Shaffer; Merlin L Robb; Nelson L Michael; Deborah L Birx; Francine E McCutchan
Short communication: HIV type 1 genetic diversity among tea plantation workers in Kericho, Kenya.
AIDS research and human retroviruses 2009;25(11):1061-4.
2009: Patricia L Earl; Catherine Cotter; Bernard Moss; Thomas VanCott; Jeffrey Currier; Leigh Anne Eller; Francine E McCutchan; Deborah L Birx; Nelson L Michael; Mary A Marovich; Merlin Robb; Josephine H Cox
Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.
Vaccine 2009;27(42):5885-95.
2008: Thippawan Chuenchitra; Chantapong Wasi; Mark de Souza; Sorachai Nitayaphan; Suda Louisirirotchanakul; Ruengpung Sutthent; Arthur E Brown; Deborah L Birx; Victoria R Polonis
Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression.
The Southeast Asian journal of tropical medicine and public health 2008;39(5):856-62.
2008: Gustavo H Kijak; Luiz Mario Janini; Sodsai Tovanabutra; eric sanders-buell; Miguel Angel Arroyo; Merlin L Robb; Nelson L Michael; Deborah L Birx; Francine E McCutchan
Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells.
Virology 2008;376(1):101-11.
2008: Bruce K Brown; Lindsay Wieczorek; eric sanders-buell; Andrew Rosa Borges; Merlin L Robb; Deborah L Birx; Nelson L Michael; Francine E McCutchan; Victoria R Polonis
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.
Virology 2008;375(2):529-38.
2008: Rukia S Kibaya; Christian T Bautista; Frederick K Sawe; Douglas N Shaffer; Warren B Sateren; Paul T Scott; Nelson L Michael; Merlin L Robb; Deborah L Birx; Mark de Souza
Reference ranges for the clinical laboratory derived from a rural population in Kericho, Kenya.
PloS one 2008;3(10):e3327.
2007: Michael A Eller; Leigh Anne Eller; Marc S Opollo; Benson J Ouma; Peter Ouma Oballah; Lynee Galley; Chitraporn Karnasuta; Silvia Ratto Kim; Merlin L Robb; Nelson L Michael; Hannah Kibuuka; Fred Wabwire-Mangen; Barney S Graham; Deborah L Birx; Mark de Souza; Josephine H Cox
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans.
Vaccine 2007;25(45):7737-42.
2007: Matthew LeBreton; Otto Yang; Ubald Tamoufe; Eitel Mpoudi-Ngole; Judith N Torimiro; Cyrille F Djoko; Jean K Carr; A Tassy Prosser; Anne W Rimoin; Deborah L Birx; Donald S. Burke; Nathan D Wolfe
Exposure to wild primates among HIV-infected persons.
Emerging infectious diseases 2007;13(10):1579-82.
2007: Prasert Thongcharoen; Vinai Suriyanon; Robert M Paris; Chirasak Khamboonruang; Mark de Souza; Silvia Ratto-Kim; Chitraporn Karnasuta; Victoria R Polonis; Lynn Baglyos; Raphaelle El Habib; Sanjay Gurunathan; Susan Barnett; Arthur E Brown; Deborah L Birx; John G McNeil; Jerome H Kim
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):48-55.
2007: Lindsay M Eyzaguirre; Isidora B Erasilova; Yuka Nadai; Magdi D Saad; Natalya G Kovtunenko; Peter J Gomatos; Victoria V Zeman; Boulos A Botros; Jose L Sanchez; Deborah L Birx; Kenneth C Earhart; Jean K Carr
Genetic characterization of HIV-1 strains circulating in Kazakhstan.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):19-23.
2007: Douglas N Shaffer; Christian T Bautista; Warren B Sateren; Frederick K Sawe; Stanley C Kiplangat; Argwings O Miruka; Philip O Renzullo; Paul T Scott; Merlin L Robb; Nelson L Michael; Deborah L Birx
The protective effect of circumcision on HIV incidence in rural low-risk men circumcised predominantly by traditional circumcisers in Kenya: two-year follow-up of the Kericho HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2007;45(4):371-9.
2007: Sodsai Tovanabutra; Gustavo H Kijak; CHRISTOPHER BEYRER; Christiana Gammon-Richardson; Supachai Sakkhachornphop; Tasanai Vongchak; Jaroon Jittiwutikarn; Myat Htoo Razak; eric sanders-buell; Merlin L Robb; Vinai Suriyanon; Deborah L Birx; Nelson L Michael; David Celentano; Francine E McCutchan
Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand.
AIDS research and human retroviruses 2007;23(6):829-33.
2007: Sodsai Tovanabutra; Mark de Souza; Nopporn Sittisombut; Somchai Sriplienchan; Vidhaya Ketsararat; Deborah L Birx; Chirasak Khamboonrueng; Kenrad E Nelson; Francine E McCutchan; Merlin L Robb
HIV-1 genetic diversity and compartmentalization in mother/infant pairs infected with CRF01_AE.
AIDS (London, England) 2007;21(8):1050-3.
2007: Alleluiah Rutebemberwa; J W Bess; B Brown; M Arroyo; Michael A Eller; Bonnie M Slike; Victoria R Polonis; Francine E McCutchan; Jeffrey R Currier; Deborah L Birx; Merlin Robb; Mary A Marovich; J D Lifson; Josephine H Cox
Evaluation of aldrithiol-2-inactivated preparations of HIV type 1 subtypes A, B, and D as reagents to monitor T cell responses.
AIDS research and human retroviruses 2007;23(4):532-42.
2007: Gustavo H Kijak; Mario Janini; Sodsai Tovanabutra; eric sanders-buell; Deborah L Birx; Merlin L Robb; Nelson L Michael; Francine E McCutchan
HyperPack: a software package for the study of levels, contexts, and patterns of APOBEC-mediated hypermutation in HIV.
AIDS research and human retroviruses 2007;23(4):554-7.
2007: Christof Geldmacher; Jeffrey R Currier; Eva Herrmann; Antelmo Haule; Ellen Kuta; Francine E McCutchan; Lilian Njovu; Steffen Geis; Oliver Hoffmann; Leonard Maboko; Carolyn Williamson; Deborah L Birx; Andreas Meyerhans; Josephine Cox; Michael Hoelscher
CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.
Journal of virology 2007;81(5):2440-8.
2007: Judith N Torimiro; Nathan D Wolfe; Alero Thomas; Maureen P Martin; Eitel Mpoudi-Ngole; Ubald Tamoufe; Deborah L Birx; Mary Carrington; Donald S. Burke; Jean K Carr
Frequency of CCR5 variants among rural populations with low HIV-1 prevalence in Cameroon.
AIDS (London, England) 2007;21(4):527-8.
2007: Gustavo H Kijak; Sodsai Tovanabutra; eric sanders-buell; Veerachai Watanaveeradej; Mark de Souza; Kenrad E Nelson; Vidhaya Ketsararat; Vilawan Gulgolgarn; Manu Wera-arpachai; Somchai Sriplienchan; Chirasak Khamboonrueng; Deborah L Birx; Merlin L Robb; Francine E McCutchan
Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2.
Virology 2007;358(1):178-91.
2007: Bruce K Brown; Nicos Karasavvas; Zoltan Beck; Gary R Matyas; Deborah L Birx; Victoria R Polonis; Carl R Alving
Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites.
Journal of virology 2007;81(4):2087-91.
2007: Christof Geldmacher; Jeffrey R Currier; Martina Gerhardt; Antelmo Haule; Leonard Maboko; Deborah L Birx; Clive Gray; Andreas Meyerhans; Josephine Cox; Michael Hoelscher
In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype.
AIDS (London, England) 2007;21(2):135-43.
2006: Deborah L Birx; William Levine
Centers for Disease Control and Prevention and authorship.
Lancet 2006;368(9551):1960-1.
2006: Miguel A Arroyo; Warren B Sateren; David Serwadda; Ronald H Gray; Maria J Wawer; Nelson K Sewankambo; Noah Kiwanuka; Godfrey Kigozi; Fred Wabwire-Mangen; Michael A Eller; Leigh Anne Eller; Deborah L Birx; Merlin L Robb; Francine E McCutchan
Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda.
Journal of acquired immune deficiency syndromes (1999) 2006;43(4):440-5.
2006: Christian T Bautista; Warren B Sateren; Jose L Sanchez; Zahid Rathore; Darrell E Singer; Deborah L Birx; Paul T Scott
HIV incidence trends among white and african-american active duty United States Army personnel (1986-2003).
Journal of acquired immune deficiency syndromes (1999) 2006;43(3):351-5.
2006: Warren B Sateren; Ginamarie Foglia; Philip O Renzullo; Lynne Elson; Monique K Wasunna; Christian T Bautista; Deborah L Birx
Epidemiology of HIV-1 infection in agricultural plantation residents in Kericho, Kenya: preparation for vaccine feasibility studies.
Journal of acquired immune deficiency syndromes (1999) 2006;43(1):102-6.
2006: Veerachai Watanaveeradej; Michael W Benenson; Mark De Souza; Narongrid Sirisopana; Sorachai Nitayaphan; Chalermsri Tontichaivanich; Ramase Amphaipit; Philip O Renzullo; Arthur E Brown; John G McNeil; Merlin L Robb; Deborah L Birx; Sodsai Tovanabutra; Jean K Carr; Francine E McCutchan
Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping.
AIDS research and human retroviruses 2006;22(8):801-7.
2006: Magdi D Saad; Alla M Shcherbinskaya; Yuka Nadai; Yuri V Kruglov; Svietlana V Antonenko; Mariya G Lyullchuk; Olga N Kravchenko; Kenneth C Earhart; Jose L Sanchez; Deborah L Birx; Jean K Carr
Molecular epidemiology of HIV Type 1 in Ukraine: birthplace of an epidemic.
AIDS research and human retroviruses 2006;22(8):709-14.
2006: Taheri Sathaliyawala; Mangala Rao; Danielle M Maclean; Deborah L Birx; Carl R Alving; Venigalla B Rao
Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.
Journal of virology 2006;80(15):7688-98.
2006: Unchalee Visawapoka; Sodsai Tovanabutra; Jeffrey R Currier; Josephine H Cox; Carl Mason; Monique Wasunna; Mathurose Ponglikitmongkol; William E Dowling; Merlin L Robb; Deborah L Birx; Francine E McCutchan
Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2.
AIDS research and human retroviruses 2006;22(7):695-702.
2006: Karl-Heinz Herbinger; Martina Gerhardt; Sucheep Piyasirisilp; Doreen Mloka; Miguel A Arroyo; Oliver Hoffmann; Leonard Maboko; Deborah L Birx; Donan Mmbando; Francine E McCutchan; Michael Hoelscher
Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, Tanzania.
AIDS research and human retroviruses 2006;22(7):599-606.
2006: Christian T Bautista; Warren B Sateren; Darrell E Singer; Jean K Carr; Deborah L Birx; Jose L Sanchez
Trends in HIV prevalence among white and African-American civilian applicants for United States Military Service, 1985 to 2003.
Journal of acquired immune deficiency syndromes (1999) 2006;42(1):68-74.
2006: Jeffrey R Currier; Unchalee Visawapoka; Sodsai Tovanabutra; Carl Mason; Deborah L Birx; Francine E McCutchan; Josephine H Cox
CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
BMC immunology 2006;7():8.
2006: Judith N Torimiro; Jean K Carr; Nathan D Wolfe; P Karacki; Maureen P Martin; X Gao; Ubald Tamoufe; A Thomas; E M Ngole; Deborah L Birx; Francine E McCutchan; Donald S. Burke; Mary Carrington
HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A*2612-B*4407 haplotype.
Tissue antigens 2006;67(1):30-7.
2005: Darrell E Singer; Noah Kiwanuka; David Serwadda; Fred Nalugoda; Linda Hird; Jamie Bulken-Hoover; Godfrey Kigozi; Jennifer A Malia; Eva K Calero; Warren B Sateren; Merlin L Robb; Fred Wabwire-Mangen; Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; Deborah L Birx; Nelson L Michael
Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.
Journal of clinical microbiology 2005;43(10):5312-5.
2005: Miguel A Arroyo; Michael Hoelscher; Warren B Sateren; Eleuter Samky; Leonard Maboko; Oliver Hoffmann; Gustavo H Kijak; Merlin Robb; Deborah L Birx; Francine E McCutchan
HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania.
AIDS (London, England) 2005;19(14):1517-24.
2005: Francine E McCutchan; Michael Hoelscher; Sodsai Tovanabutra; Sucheep Piyasirisilp; eric sanders-buell; G Ramos; Linda L Jagodzinski; Victoria R Polonis; Leonard Maboko; Donan Mmbando; Oliver Hoffmann; Gabriele Riedner; Frank von Sonnenburg; Merlin Robb; Deborah L Birx
In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection.
Journal of virology 2005;79(18):11693-704.
2005: Jean K Carr; Yuka Nadai; Lindsay M Eyzaguirre; Magdi D Saad; Mumtaz M Khakimov; Shavkat K Yakubov; Deborah L Birx; Ross R Graham; Nathan D Wolfe; Kenneth C Earhart; Jose L Sanchez
Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan.
Journal of acquired immune deficiency syndromes (1999) 2005;39(5):570-5.
2005: Alleluiah Rutebemberwa; Jeffrey R Currier; Linda L Jagodzinski; Francine E McCutchan; Deborah L Birx; Mary A Marovich; Josephine H Cox
HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides.
AIDS (London, England) 2005;19(11):1165-72.
2005: Martina Gerhardt; D Mloka; Sodsai Tovanabutra; eric sanders-buell; Oliver Hoffmann; Leonard Maboko; Donan Mmbando; Deborah L Birx; Francine E McCutchan; Michael Hoelscher
In-depth, longitudinal analysis of viral quasispecies from an individual triply infected with late-stage human immunodeficiency virus type 1, using a multiple PCR primer approach.
Journal of virology 2005;79(13):8249-61.
2005: Nathan D Wolfe; Walid Heneine; Jean K Carr; Albert D Garcia; Vedapuri Shanmugam; Ubald Tamoufe; Judith N Torimiro; A Tassy Prosser; Matthew LeBreton; Eitel Mpoudi-Ngole; Francine E McCutchan; Deborah L Birx; Thomas M Folks; Donald S. Burke; William Switzer
Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(22):7994-9.
2005: Sodsai Tovanabutra; Stephanie K Brodine; John R Mascola; Jean-louis Sankale; eric sanders-buell; Bohye Kim; Deborah L Birx; Francine E McCutchan
Characterization of complete HIV type 1 genomes from non-B subtype infections in U.S. military personnel.
AIDS research and human retroviruses 2005;21(5):424-9.
2005: Bruce K Brown; Janice M Darden; Sodsai Tovanabutra; Tamara Oblander; Julie Frost; eric sanders-buell; Mark de Souza; Deborah L Birx; Francine E McCutchan; Victoria R Polonis
Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines.
Journal of virology 2005;79(10):6089-101.
2005: Chitraporn Karnasuta; Robert M Paris; Josephine H Cox; Sorachai Nitayaphan; Punnee Pitisuttithum; Prasert Thongcharoen; Arthur E Brown; Sanjay Gurunathan; Jim Tartaglia; William L Heyward; John G McNeil; Deborah L Birx; Mark de Souza
Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.
Vaccine 2005;23(19):2522-9.
2005: Jeffrey R Currier; Matthew E Harris; Josephine H Cox; Francine E McCutchan; Deborah L Birx; Shlomo Maayan; Guido Ferrari
Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians.
AIDS research and human retroviruses 2005;21(3):239-45.
2004: Nathan D Wolfe; Tassy A Prosser; Jean K Carr; Ubald Tamoufe; Eitel Mpoudi-Ngole; Judith N Torimiro; Matthew LeBreton; Francine E McCutchan; Deborah L Birx; Donald S. Burke
Exposure to nonhuman primates in rural Cameroon.
Emerging infectious diseases 2004;10(12):2094-9.
2004: Roberta L Richards; Mangala Rao; Thomas C VanCott; Gary R Matyas; Deborah L Birx; Carl R Alving
Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen.
Immunology and cell biology 2004;82(5):531-8.
2004: Mangala Rao; Gary R Matyas; Thomas C VanCott; Deborah L Birx; Carl R Alving
Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope protein.
Immunology and cell biology 2004;82(5):523-30.
2004: Gladys Carrion; Lindsay M Eyzaguirre; Silvia M Montano; Victor A Laguna-Torres; Margarita Serra; N Aguayo; María M Avila; Dora Ruchansky; María A Pando; Jose Vinoles; Lautaro Matas; A Barboza; Gloria Chauca; A Romero; A Galeano; Patrick J Blair; Mercedes Weissenbacher; Deborah L Birx; Jose L Sanchez; James G Olson; Jean K Carr
Documentation of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay.
AIDS research and human retroviruses 2004;20(9):1022-5.
2004: Robert M Paris; Sasitorn Bejrachandra; Chitraporn Karnasuta; Dasnayanee Chandanayingyong; Warunee Kunachiwa; Nipapan Leetrakool; S Prakalapakorn; Prasert Thongcharoen; S Nittayaphan; Punnee Pitisuttithum; Vinai Suriyanon; Sanjay Gurunathan; John G McNeil; Arthur E Brown; Deborah L Birx; Mark de Souza
HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting.
Tissue antigens 2004;64(3):251-6.
2004: Sorachai Nitayaphan; Punnee Pitisuttithum; Chitraporn Karnasuta; Chirapa Eamsila; Mark de Souza; Patricia Morgan; Victoria R Polonis; Michael W Benenson; Thomas C VanCott; Silvia Ratto-Kim; Jerome Kim; Darawan Thapinta; Robin P Garner; Valai Bussaratid; Pricha Singharaj; Raphaelle El Habib; Sanjay Gurunathan; William L Heyward; Deborah L Birx; John McNeil; Arthur E Brown
Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.
The Journal of infectious diseases 2004;190(4):702-6.
2004: Miguel A Arroyo; Michael Hoelscher; eric sanders-buell; Karl-Heinz Herbinger; Eleuter Samky; Leonard Maboko; Oliver Hoffmann; Merlin R Robb; Deborah L Birx; Francine E McCutchan
HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania.
AIDS research and human retroviruses 2004;20(8):895-901.
2004: Francine E McCutchan; Jean-louis Sankale; Souleymane M'Boup; Bohye Kim; Sodsai Tovanabutra; Donald J Hamel; Stephanie K Brodine; Phyllis J Kanki; Deborah L Birx
HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321.
AIDS research and human retroviruses 2004;20(8):819-26.
2004: Ginamarie Foglia; G Donald Royster; K Monique Wasunna; Rukia Kibaya; Jennifer A Malia; Eva K Calero; Warren B Sateren; Philip O Renzullo; Merlin L Robb; Deborah L Birx; Nelson L Michael
Use of rapid and conventional testing technologies for human immunodeficiency virus type 1 serologic screening in a rural Kenyan reference laboratory.
Journal of clinical microbiology 2004;42(8):3850-2.
2004: Wannee Kantakamalakul; Mark de Souza; Chitraporn Karnasuta; Arthur Brown; Sanjay Gurunathan; Deborah L Birx; Prasert Thongcharoen; The Taveg
Enhanced sensitivity of detection of cytotoxic T lymphocyte responses to HIV type 1 proteins using an extended in vitro stimulation period for measuring effector function in volunteers enrolled in an ALVAC-HIV phase I/II prime boost vaccine trial in Thailand.
AIDS research and human retroviruses 2004;20(6):642-4.
2004: Guido Ferrari; Jeffrey R Currier; Matthew E Harris; Stella Finkelstein; Angelica de Oliveira; Debra Barkhan; Josephine H Cox; Michael Zeira; Kent J Weinhold; Nancy L Reinsmoen; Francine E McCutchan; Deborah L Birx; Saladin Osmanov; Shlomo Maayan
HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians.
Human immunology 2004;65(6):648-59.
2004: Wendy B Bernstein; Josephine H Cox; Naomi E Aronson; LaRee Tracy; Katia Schlienger; Silvia Ratto-Kim; Robin P Garner; Julio Cotte; Zhaohui Zheng; Lena Winestone; Caroline Liebig; Lynee M Galley; Mark Connors; Deborah L Birx; Richard G Carroll; Bruce L Levine
Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4(+) T cells to HIV-infected persons.
Clinical immunology (Orlando, Fla.) 2004;111(3):262-74.
2004: Noah Kiwanuka; Merlin Robb; Godfrey Kigozi; Deborah L Birx; James Philips; Fred Wabwire-Mangen; Maria J Wawer; Fred Nalugoda; Nelson K Sewankambo; David Serwadda; Ronald H Gray
Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda.
Journal of acquired immune deficiency syndromes (1999) 2004;36(2):721-5.
2004: Silvia Ratto-Kim; Robin P Garner; Jerome H Kim; Linda L Jagodzinski; Nelson L Michael; Robert M Paris; Robert R Redfield; Deborah L Birx
Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort.
The Journal of infectious diseases 2004;189(11):1988-95.
2004: Gustavo H Kijak; eric sanders-buell; Nathan D Wolfe; Eitel Mpoudi-Ngole; Bohye Kim; Bruce Brown; Merlin L Robb; Deborah L Birx; Donald S. Burke; Jean K Carr; Francine E McCutchan
Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa.
AIDS research and human retroviruses 2004;20(5):521-30.
2004: Sodsai Tovanabutra; CHRISTOPHER BEYRER; Supachai Sakkhachornphop; Myat Htoo Razak; Gabriela L Ramos; Tasanai Vongchak; Kittipong Rungruengthanakit; Pongpran Saokhieo; Kwanchanok Tejafong; Bohye Kim; Mark de Souza; Merlin L Robb; Deborah L Birx; Jaroon Jittiwutikarn; Vinai Suriyanon; David Celentano; Francine E McCutchan
The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002.
AIDS research and human retroviruses 2004;20(5):465-75.
2004: Nathan D Wolfe; William Switzer; Jean K Carr; Vinod Bhullar; Vedapuri Shanmugam; Ubald Tamoufe; A Tassy Prosser; Judith N Torimiro; Anthony Wright; Eitel Mpoudi-Ngole; Francine E McCutchan; Deborah L Birx; Thomas M Folks; Donald S. Burke; Walid Heneine
Naturally acquired simian retrovirus infections in central African hunters.
Lancet 2004;363(9413):932-7.
2004: Ronnarit Haponsaph; Janice M Darden; Somsak Chantakulkij; Nongluck Sannoi; Mark de Souza; Arthur E Brown; Deborah L Birx; Victoria R Polonis; Kovit Pattanapanyasat
In vitro susceptibility of Thai seronegative donor CD8+ T lymphocytes to human immunodeficiency virus-1 (HIV-1) infection.
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 2004;22(1):39-48.
2004: Scott Wegner; Mark R Wallace; Naomi E Aronson; Sybil A Tasker; David L Blazes; Cindy Tamminga; Susan Fraser; Matthew J Dolan; Kevin T Stephan; Nelson L Michael; Linda L Jagodzinski; Maryanne Vahey; Joyce L Gilcrest; LaRee Tracy; Mark J Milazzo; Daniel J Murphy; Paula McKenna; Kurt Hertogs; Alex Rinehart; Brendan Larder; Deborah L Birx
Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(5):723-30.
2004: John G McNeil; Margaret I Johnston; Deborah L Birx; Edmund C Tramont
Policy rebuttal. HIV vaccine trial justified.
Science (New York, N.Y.) 2004;303(5660):961.
2004: Gustavo H Kijak; Jeffrey R Currier; Sodsai Tovanabutra; Josephine H Cox; Nelson L Michael; Scott Wegner; Deborah L Birx; Francine E McCutchan
Lost in translation: implications of HIV-1 codon usage for immune escape and drug resistance.
AIDS reviews 2004;6(1):54-60.
2003: Matthew E Harris; Shlomo Maayan; Bohye Kim; Michael Zeira; Guido Ferrari; Deborah L Birx; Francine E McCutchan
A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions.
AIDS research and human retroviruses 2003;19(12):1125-33.
2003: Iqbal H Chowdhury; Arash Farhadi; Xiao-Fan Wang; Merlin L Robb; Deborah L Birx; Jerome H Kim
Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
International journal of cancer. Journal international du cancer 2003;107(4):603-11.
2003: Jeffrey R Currier; William E Dowling; K Monique Wasunna; Uzma Alam; Carl Mason; Merlin L Robb; Jean K Carr; Francine E McCutchan; Deborah L Birx; Josephine H Cox
Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans.
AIDS (London, England) 2003;17(15):2149-57.
2003: Veerachai Watanaveeradej; Mark de Souza; Michael W Benenson; Narongrid Sirisopana; Sorachai Nitayaphan; Penprapa Chanbancherd; Arthur E Brown; eric sanders-buell; Deborah L Birx; Francine E McCutchan; Jean K Carr
Subtype C/CRF01_AE recombinant HIV-1 found in Thailand.
AIDS (London, England) 2003;17(14):2138-40.
2003: Jerome H Kim; Punnee Pitisuttithum; Chirasak Kamboonruang; Thippawan Chuenchitra; John R Mascola; Sarah Schlesinger Frankel; Mark de Souza; Victoria R Polonis; Robert McLinden; Anna Sambor; Arthur E Brown; Benjaluck Phonrat; Kittipong Rungruengthanakit; Anne-Marie Duliege; Merlin L Robb; John McNeil; Deborah L Birx
Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1.
AIDS research and human retroviruses 2003;19(9):807-16.
2003: Victoria R Polonis; Mark de Souza; Janice M Darden; Somsak Chantakulkij; Thippawan Chuenchitra; Sorachai Nitayaphan; Arthur E Brown; Merlin L Robb; Deborah L Birx
Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients.
Journal of virology 2003;77(15):8570-6.
2003: Punnee Pitisuttithum; Sorachai Nitayaphan; Prasert Thongcharoen; Chirasak Khamboonruang; Jerome Kim; Mark de Souza; Thippawan Chuenchitra; Robin P Garner; Darawan Thapinta; Victoria R Polonis; Silvia Ratto-Kim; Penprapa Chanbancherd; Joseph Chiu; Deborah L Birx; Anne-Marie Duliege; John G McNeil; Arthur E Brown
Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.
The Journal of infectious diseases 2003;188(2):219-27.
2003: Sodsai Tovanabutra; Veerachai Watanaveeradej; Kwanjai Viputtikul; Mark de Souza; Myat Htoo Razak; Vinai Suriyanon; Jaroon Jittiwutikarn; Somchai Sriplienchan; Sorachai Nitayaphan; Michael W Benenson; Narongrid Sirisopana; Philip O Renzullo; Arthur E Brown; Merlin L Robb; CHRISTOPHER BEYRER; David Celentano; John G McNeil; Deborah L Birx; Jean K Carr; Francine E McCutchan
A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand.
AIDS research and human retroviruses 2003;19(7):561-7.
2003: Boonrat Tassaneetrithep; Timothy Burgess; Angela Granelli-Piperno; Christine Trumpfheller; Jennifer Finke; Wellington Sun; Michael A Eller; Kovit Pattanapanyasat; Suttipant Sarasombath; Deborah L Birx; Ralph M Steinman; Sarah J Schlesinger; Mary A Marovich
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells.
The Journal of experimental medicine 2003;197(7):823-9.
2003: Gladys Carrion; Jesse Hierholzer; Silvia M Montano; Araceli Alava; Lautaro Matas; A Guevara; Victor A Laguna-Torres; C Mosquera; Kevin Russell; Gloria Chauca; Tadeusz J Kochel; Deborah L Birx; Jose L Sanchez; Jean K Carr
Circulating recombinant form CRF02_AG in South America.
AIDS research and human retroviruses 2003;19(4):329-32.
2003: Thippawan Chuenchitra; Chantapong Wasi; Suda Louisirirojchanakul; Sorachai Nitayaphan; Ruengpung Sutthent; Josephine H Cox; Mark de Souza; Arthur E Brown; Deborah L Birx; Victoria R Polonis
Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression.
AIDS research and human retroviruses 2003;19(4):293-305.
2003: Warren B Sateren; Philip O Renzullo; Jean K Carr; Deborah L Birx; John G McNeil
HIV-1 infection among civilian applicants for US military service, 1985 to 2000: epidemiology and geography.
Journal of acquired immune deficiency syndromes (1999) 2003;32(2):215-22.
2003: Iqbal H Chowdhury; Xiao-Fan Wang; Nathaniel R Landau; Merlin L Robb; Victoria R Polonis; Deborah L Birx; Jerome H Kim
HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest.
Virology 2003;305(2):371-7.
2003: Silvia Ratto-Kim; Lawrence D Loomis-Price; Naomi E Aronson; Janelle Grimes; Cristin Hill; Chevelle Williams; Raphaelle El Habib; Deborah L Birx; Jerome H Kim
Comparison between env-specific T-cell epitopic responses in HIV-1-uninfected adults immunized with combination of ALVAC-HIV(vCP205) plus or minus rgp160MN/LAI-2 and HIV-1-infected adults.
Journal of acquired immune deficiency syndromes (1999) 2003;32(1):9-17.
2002: Jesse Hierholzer; Silvia M Montano; Michael Hoelscher; Monica Negrete; Matthew Hierholzer; María M Avila; Manuel Gómez Carrillo; José Russi; Jose Vinoles; Araceli Alava; Maria E Acosta; Alberto Gianella; Ronald Andrade; Jose L Sanchez; Gladys Carrion; Jorge L Sanchez; Kevin Russell; Merlin Robb; Deborah L Birx; Francine E McCutchan; Jean K Carr
Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina.
AIDS research and human retroviruses 2002;18(18):1339-50.
2002: Matthew E Harris; David Serwadda; Nelson K Sewankambo; Bohye Kim; Godfrey Kigozi; Noah Kiwanuka; James B Phillips; Fred Wabwire; Mary Meehen; Tom Lutalo; James R Lane; Randall Merling; Ronald H Gray; Maria J Wawer; Deborah L Birx; Merlin L Robb; Francine E McCutchan
Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate.
AIDS research and human retroviruses 2002;18(17):1281-90.
2002: Kwanjai Viputtijul; Mark de Souza; Rapee Trichavaroj; Jean K Carr; Sodsai Tovanabutra; Francine E McCutchan; Somchai Sriplienchan; Puangmalee Buapunth; Cheodchai Chuenchitra; John G McNeil; Deborah L Birx; Arthur E Brown; Sorachai Nitayaphan
Heterosexually acquired CRF01_AE/B recombinant HIV type 1 found in Thailand.
AIDS research and human retroviruses 2002;18(16):1235-7.
2002: Mary A Marovich; John R Mascola; Michael A Eller; Mark K Louder; Pierre A Caudrelier; Raphaelle El Habib; Silvia Ratto-Kim; Josephine H Cox; Jeffrey R Currier; Bruce L Levine; Carl H June; Wendy B Bernstein; Merlin L Robb; Beatrice Schuler-Thurner; Ralph M Steinman; Deborah L Birx; Sarah Schlesinger-Frankel
Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells.
The Journal of infectious diseases 2002;186(9):1242-52.
2002: Michael Hoelscher; William E Dowling; eric sanders-buell; Jean K Carr; Matthew E Harris; Angelika Thomschke; Merlin L Robb; Deborah L Birx; Francine E McCutchan
Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay.
AIDS (London, England) 2002;16(15):2055-64.
2002: Matthew Hierholzer; Ross R Graham; I El Khidir; Sybil Tasker; Magdi Darwish; Gail D Chapman; Ademola H Fagbami; Atef Soliman; Deborah L Birx; Francine E McCutchan; Jean K Carr
HIV type 1 strains from East and West Africa are intermixed in Sudan.
AIDS research and human retroviruses 2002;18(15):1163-6.
2002: F E McClutchan; Jean K Carr; D Murphy; Sucheep Piyasirisilp; F Gao; B Hahn; XIAOFANG YU; CHRISTOPHER BEYRER; Deborah L Birx
Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China.
AIDS research and human retroviruses 2002;18(15):1135-40.
2002: William E Dowling; Bohye Kim; Carl Mason; K Monique Wasunna; Uzma Alam; Lynne Elson; Deborah L Birx; Merlin L Robb; Francine E McCutchan; Jean K Carr
Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants.
AIDS (London, England) 2002;16(13):1809-20.
2002: Maria A Papathanasopoulos; Tonie Cilliers; Lynn Morris; John Mokili; William E Dowling; Deborah L Birx; Francine E McCutchan
Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa.
AIDS research and human retroviruses 2002;18(12):879-86.
2002: John Mokili; Melissa Rogers; Jean K Carr; Peter Simmonds; Johnny M Bopopi; Brian Foley; Bette T Korber; Deborah L Birx; Francine E McCutchan
Identification of a novel clade of human immunodeficiency virus type 1 in Democratic Republic of Congo.
AIDS research and human retroviruses 2002;18(11):817-23.
2002: Jeffrey R Currier; Mark de Souza; Penprapa Chanbancherd; Wendy B Bernstein; Deborah L Birx; Josephine H Cox
Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Journal of virology 2002;76(10):4971-86.
2002: Jeffrey R Currier; Ellen Kuta; Ellen Turk; Lyndsay B Earhart; Lawrence D Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.
Journal of immunological methods 2002;260(1-2):157-72.
2002: Eric Sandström; Deborah L Birx
HIV vaccine trials in Africa.
AIDS (London, England) 2002;16 Suppl 4():S89-95.
2002: J Anderson; Michael A Eller; M Finkelman; Deborah L Birx; S Schlesinger-Frankel; Mary A Marovich
False positive endotoxin results in a DC product caused by (1-->3)-beta-D-glucans acquired from a sterilizing cellulose filter.
Cytotherapy 2002;4(6):557-9.
2002: Bruce L Levine; Wendy B Bernstein; Naomi E Aronson; Katia Schlienger; Julio Cotte; Steven Perfetto; Mary J Humphries; Silvia Ratto-Kim; Deborah L Birx; Carolyn Steffens; Alan Landay; Richard G Carroll; Carl H June
Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.
Nature medicine 2002;8(1):47-53.
2001: Mary A Marovich; G Grouard-Vogel; Mark K Louder; Michael A Eller; Wellington Sun; Shuenn-Jue Wu; R Putvatana; G Murphy; B Tassaneetrithep; Timothy Burgess; Deborah L Birx; C Hayes; S Schlesinger-Frankel; John R Mascola
Human dendritic cells as targets of dengue virus infection.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 2001;6(3):219-24.
2001: Jean K Carr; M Avila; M Gomez Carrillo; Horacio Salomon; Jesse Hierholzer; Veerachai Watanaveeradej; María A Pando; Monica Negrete; Kevin L Russell; J Sanchez; Deborah L Birx; R Andrade; Jose Vinoles; Francine E McCutchan
Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America.
AIDS (London, England) 2001;15(15):F41-7.
2001: Philip O Renzullo; Warren B Sateren; Robin P Garner; M J Milazzo; Deborah L Birx; John G McNeil
HIV-1 seroconversion in United States Army active duty personnel, 1985-1999.
AIDS (London, England) 2001;15(12):1569-74.
2001: Michael Hoelscher; B Kim; Leonard Maboko; F Mhalu; Frank von Sonnenburg; Deborah L Birx; Francine E McCutchan
High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania.
AIDS (London, England) 2001;15(12):1461-70.
2001: Jean K Carr; Judith N Torimiro; Nathan D Wolfe; M N Eitel; B Kim; eric sanders-buell; Linda L Jagodzinski; D Gotte; Donald S. Burke; Deborah L Birx; Francine E McCutchan
The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon.
Virology 2001;286(1):168-81.
2001: A E Brown; Matthew J Dolan; Nelson L Michael; S Zhou; Steven Perfetto; C Hawkes; M Robb; J Lane; DL Mayers; J G McNeil; J D Malone; R Garner; Deborah L Birx
Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease: contribution of HIV-1 RNA and T lymphocyte subset quantitation.
Military medicine 2001;166(7):571-6.
2001: Sodsai Tovanabutra; Victoria R Polonis; Mark de Souza; Rapee Trichavaroj; Penprapa Chanbancherd; Bohye Kim; eric sanders-buell; Sorachai Nitayaphan; A Brown; M R Robb; Deborah L Birx; Francine E McCutchan; Jean K Carr
First CRF01_AE/B recombinant of HIV-1 is found in Thailand.
AIDS (London, England) 2001;15(8):1063-5.
2001: Wannee Kantakamalakul; J Cox; Uraiwan Kositanont; Sontana Siritantikorn; K Limbach; Deborah L Birx; Prasert Thongcharoen; Pilaipan Puthavathana
Cytotoxic T lymphocyte responses to vaccinia virus antigens but not HIV-1 subtype E envelope protein seen in HIV-1 seronegative Thais.
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 2001;19(1):17-22.
2001: Mark de Souza; Rapee Trichavaroj; Somchai Sriplienchan; Puangmalee Buapunth; Philip O Renzullo; Cheodchai Chuenchitra; Deborah L Birx; Merlin L Robb; Arthur E Brown
Detection and quantification of HIV type 1 RNA in nasopharyngeal washes from HIV-infected subjects.
AIDS research and human retroviruses 2001;17(3):229-32.
2001: Victoria R Polonis; Mark de Souza; Penprapa Chanbancherd; Somsak Chantakulkij; Achara Jugsudee; Lawrence D Loomis-Price; Thomas C VanCott; Robin P Garner; Lauri E Markowitz; Arthur E Brown; Deborah L Birx
HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies.
AIDS research and human retroviruses 2001;17(1):69-79.
2000: Mika Salminen; Philip K Ehrenberg; John R Mascola; Debora Elizabeth Sites (Dayhoff); R Merling; B Blake; Mark K Louder; S Hegerich; Victoria R Polonis; Deborah L Birx; Merlin L Robb; Francine E McCutchan; Nelson L Michael
Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction.
Virology 2000;278(1):103-10.
2000: George Watt; Pacharee Kantipong; Mark de Souza; Penprapa Chanbancherd; Krisada Jongsakul; R Ruangweerayud; Lawrence D Loomis-Price; Victoria R Polonis; Khin Saw Aye Myint; Deborah L Birx; Arthur E Brown; S Krishna
HIV-1 suppression during acute scrub-typhus infection.
Lancet 2000;356(9228):475-9.
2000: Mark de Souza; Chitraporn Karnasuta; Arthur E Brown; Lauri E Markowitz; Sorachai Nitayaphan; Robin P Garner; John G McNeil; Deborah L Birx; Josephine H Cox
A comparative study of the impact of HIV infection on natural killer cell number and function in Thais and North Americans.
AIDS research and human retroviruses 2000;16(11):1061-6.
2000: Shuenn-Jue Wu; G Grouard-Vogel; Wellington Sun; John R Mascola; Elena F Brachtel; R Putvatana; Mark K Louder; Luis Filgueira; Mary A Marovich; Henry K Wong; Andrew Blauvelt; Gerald S Murphy; Merlin L Robb; B L Innes; Deborah L Birx; Curtis G Hayes; Sarah Schlesinger Frankel
Human skin Langerhans cells are targets of dengue virus infection.
Nature medicine 2000;6(7):816-20.
2000: Arthur E Brown; Lauri E Markowitz; Sorachai Nitayaphan; Patricia Morgan; Suchitra Sukwit; Suchada Chinaworapong; S Leelasupasri; Deborah L Birx
DTH responsiveness of HIV-infected Thai adults.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2000;83(6):633-9.
2000: Janice M Darden; Victoria R Polonis; Mark de Souza; Somsak Chantakulkij; Arthur E Brown; Deborah L Birx; Kovit Pattanapanyasat
A flow cytometric method for measuring neutralization of HIV-1 subtype B and E primary isolates.
Cytometry 2000;40(2):141-50.
2000: Francine E McCutchan; K Viputtigul; Mark de Souza; Jean K Carr; Lauri E Markowitz; Puangmalee Buapunth; John G McNeil; Merlin L Robb; Sorachai Nitayaphan; Deborah L Birx; Arthur E Brown
Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand.
AIDS research and human retroviruses 2000;16(8):801-5.
2000: Deborah L Birx; Lawrence D Loomis-Price; Naomi E Aronson; J Brundage; Charles Davis; L Deyton; Robin P Garner; F Gordin; D Henry; W Holloway; T Kerkering; R Luskin-Hawk; John McNeil; N Michael; P Foster Pierce; D Poretz; Silvia Ratto-Kim; P Renzullo; N Ruiz; KV Sitz; G Smith; Carol O Tacket; M Thompson; E Tramont; B Yangco; R Yarrish; Robert R Redfield
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.
The Journal of infectious diseases 2000;181(3):881-9.
2000: Sorachai Nitayaphan; Chirasak Khamboonruang; N Sirisophana; Patricia Morgan; Joseph Chiu; Anne-Marie Duliege; Cheodchai Chuenchitra; T Supapongse; Kittipong Rungruengthanakit; Mark de Souza; John R Mascola; K Boggio; Silvia Ratto-Kim; Lauri E Markowitz; Deborah L Birx; Vinai Suriyanon; John G McNeil; Arthur E Brown; Rodney A Michael
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences.
Vaccine 2000;18(15):1448-55.
2000: John R Mascola; Gabriela Stiegler; Thomas C VanCott; H Katinger; C B Carpenter; C E Hanson; H Beary; D Hayes; Sarah Schlesinger Frankel; Deborah L Birx; Mark G Lewis
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.
Nature medicine 2000;6(2):207-10.
1999: Stephanie K Brodine; Richard A Shaffer; Monica J Starkey; Sybil A Tasker; J L Gilcrest; Mark K Louder; Anthony J Barile; Thomas C VanCott; Maryanne Vahey; Francine E McCutchan; Deborah L Birx; D D Richman; John R Mascola
Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion.
Annals of internal medicine 1999;131(7):502-6.
1999: Jean K Carr; Tiina Laukkanen; Mika Salminen; Jan Albert; A Alaeus; B Kim; eric sanders-buell; Deborah L Birx; Francine E McCutchan
Characterization of subtype A HIV-1 from Africa by full genome sequencing.
AIDS (London, England) 1999;13(14):1819-26.
1999: Josephine H Cox; Robin P Garner; Robert R Redfield; Naomi E Aronson; Charles Davis; N Ruiz; Deborah L Birx
Antibody-dependent cellular cytotoxicity in HIV type 1-infected patients receiving VaxSyn, a recombinant gp160 envelope vaccine.
AIDS research and human retroviruses 1999;15(9):847-54.
1999: Thomas C VanCott; John R Mascola; Lawrence D Loomis-Price; F Sinangil; N Zitomersky; John McNeil; Merlin L Robb; Deborah L Birx; S Barnett
Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope.
Journal of virology 1999;73(6):4640-50.
1999: John R Mascola; Mark G Lewis; Gabriela Stiegler; D Harris; Thomas C VanCott; D Hayes; Mark K Louder; C R Brown; Christine V Sapan; Sarah Schlesinger Frankel; Y Lu; Merlin L Robb; H Katinger; Deborah L Birx
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.
Journal of virology 1999;73(5):4009-18.
1999: KV Sitz; Silvia Ratto-Kim; A S Hodgkins; Merlin L Robb; Deborah L Birx
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls.
The Journal of infectious diseases 1999;179(4):817-24.
1999: Mark G Lewis; Jake Yalley-Ogunro; J J Greenhouse; Terrence Brennan; J B Jiang; Thomas C VanCott; Y Lu; G A Eddy; Deborah L Birx
Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus.
Journal of virology 1999;73(2):1262-70.
1999: Silvia Ratto-Kim; KV Sitz; Robin P Garner; Jerome H Kim; Charles Davis; Naomi E Aronson; N Ruiz; K Tencer; Robert R Redfield; Deborah L Birx
Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative response.
The Journal of infectious diseases 1999;179(2):337-44.
1999: KV Sitz; Deborah L Birx
Lymphocyte proliferation assay.
Methods in molecular medicine 1999;17():343-53.
1999: CHRISTOPHER BEYRER; Andrew W Artenstein; Sungwal Rugpao; H Stephens; Thomas C VanCott; Merlin L Robb; M Rinkaew; Deborah L Birx; Chirasak Khamboonruang; Peter Zimmerman; Kenrad E Nelson; Chawalit Natpratan
Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group.
The Journal of infectious diseases 1999;179(1):59-67.
1998: Dean L Mann; R P Garner; Debora Elizabeth Sites (Dayhoff); K Cao; M A Fernández-Viña; Charles Davis; Naomi E Aronson; N Ruiz; Deborah L Birx; Nelson L Michael
Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans.
The Journal of infectious diseases 1998;178(6):1799-802.
1998: Sarah Schlesinger Frankel; Ralph M Steinman; Nelson L Michael; S R Kim; N Bhardwaj; Melissa Pope; Mark K Louder; Philip K Ehrenberg; P W Parren; D R Burton; H Katinger; Thomas C VanCott; Merlin L Robb; Deborah L Birx; John R Mascola
Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells.
Journal of virology 1998;72(12):9788-94.
1998: Nicholas M Stamatos; John R Mascola; VS Kalyanaraman; Mark K Louder; L M Frampton; Deborah L Birx; Thomas C VanCott
Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140.
Journal of virology 1998;72(12):9656-67.
1998: Lawrence D Loomis-Price; Josephine H Cox; John R Mascola; Thomas C VanCott; Nelson L Michael; T R Fouts; Robert R Redfield; Merlin L Robb; B Wahren; H W Sheppard; Deborah L Birx
Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection.
The Journal of infectious diseases 1998;178(5):1306-16.
1998: Julia Lynch; Mark de Souza; M D Robb; Lauri E Markowitz; Sorachai Nitayaphan; C V Sapan; Dean L Mann; Deborah L Birx; Josephine H Cox
Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais.
The Journal of infectious diseases 1998;178(4):1040-6.
1998: Jean K Carr; Mika Salminen; Jan Albert; eric sanders-buell; D Gotte; Deborah L Birx; Francine E McCutchan
Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants.
Virology 1998;247(1):22-31.
1998: John R Mascola; John G McNeil; Deborah L Birx
Vaccine reactions.
Nature medicine 1998;4(7):746.
1998: Thomas C VanCott; RW Kaminski; John R Mascola; VS Kalyanaraman; Nabila M Wassef; Carl R Alving; J T Ulrich; G H Lowell; Deborah L Birx
HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):2000-12.
1997: Silvia Ratto-Kim; KV Sitz; A M Scherer; Jerome H Kim; D W Anderson; M E Nau; Dean L Mann; Pradip N Akolkar; Beena Gulwani-Akolkar; Jack Silver; Deborah L Birx
Comparison of HIV-1 envelope-specific CD4+ T cell lines simultaneously established from peripheral blood mononuclear cells and lymph node biopsy in HIV-1-infected individuals.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(10):5162-7.
1997: R J McLinden; B Lewis; Nelson L Michael; Robert R Redfield; Deborah L Birx; J H Kim
Correlation of tumor suppressor P53 RNA expression with human immunodeficiency virus disease in rapid and slow progressors.
Journal of human virology 1997;1(1):30-6.
1997: KV Sitz; Lawrence D Loomis-Price; Silvia Ratto-Kim; Julie Kenner; Purnima Sau; K H Eckels; Robert R Redfield; Deborah L Birx
Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected persons.
The Journal of infectious diseases 1997;176(4):1085-9.
1997: Melissa Pope; Sarah Schlesinger Frankel; John R Mascola; Alexandra Trkola; F Isdell; Deborah L Birx; Donald S. Burke; David D Ho; John P Moore
Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism.
Journal of virology 1997;71(10):8001-7.
1997: John R Mascola; Mark K Louder; Thomas C VanCott; Christine V Sapan; John S Lambert; L R Muenz; B Bunow; Deborah L Birx; Merlin L Robb
Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.
Journal of virology 1997;71(10):7198-206.
1997: Lawrence D Loomis-Price; M Levi; P R Burnett; J E van Hamont; R A Shafer; B Wahren; Deborah L Birx
Linear epitope mapping of humoral responses induced by vaccination with recombinant HIV-1 envelope protein gp160.
Journal of industrial microbiology & biotechnology 1997;19(1):58-65.
1997: Nelson L Michael; Arthur E Brown; R F Voigt; Sarah Schlesinger Frankel; John R Mascola; K S Brothers; Mark K Louder; Deborah L Birx; Sharon Cassol
Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection--evidence for highly susceptible human hosts.
The Journal of infectious diseases 1997;175(6):1352-9.
1997: Thomas C VanCott; John R Mascola; RW Kaminski; VS Kalyanaraman; P L Hallberg; P R Burnett; J T Ulrich; D J Rechtman; Deborah L Birx
Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160.
Journal of virology 1997;71(6):4319-30.
1997: R J Rodriguez; Debora Elizabeth Sites (Dayhoff); G Chang; Sharon Cassol; Deborah L Birx; A W Artenstein; Nelson L Michael
Comparison of serum and plasma viral RNA measurements in primary and chronic human immunodeficiency virus type 1 infection.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;15(1):49-53.
1997: Jerome H Kim; J E Loveland; KV Sitz; Silvia Ratto-Kim; R J Mclinden; K Tencer; K Davis; Donald S. Burke; R N Boswell; Robert R Redfield; Deborah L Birx
Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1.
Clinical and experimental immunology 1997;108(2):243-50.
1997: Nelson L Michael; G Chang; J H Kim; Deborah L Birx
Dynamics of cell-free viral burden in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;14(3):237-42.
1997: Nelson L Michael; G Chang; Leslie G Louie; John R Mascola; D Dondero; Deborah L Birx; Haynes W Sheppard
The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.
Nature medicine 1997;3(3):338-40.
1997: R A McDonald; DL Mayers; RC Chung; KF Wagner; Silvia Ratto-Kim; Deborah L Birx; Nelson L Michael
Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function.
Journal of virology 1997;71(3):1871-9.
1997: G H Lowell; RW Kaminski; Thomas C VanCott; B Slike; K Kersey; E Zawoznik; Lawrence D Loomis-Price; G Smith; Robert R Redfield; S Amselem; Deborah L Birx
Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG.
The Journal of infectious diseases 1997;175(2):292-301.
1997: Andrew W Artenstein; Thomas C VanCott; KV Sitz; Merlin L Robb; KF Wagner; S C Veit; A F Rogers; Robin P Garner; J W Byron; P R Burnett; Deborah L Birx
Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information.
The Journal of infectious diseases 1997;175(2):265-71.
1996: Deborah L Birx; Thomas C VanCott; Nelson L Michael; J McNeil; Nicholas M Stamatos; Bruce L Gilliam; R Davis; Jean K Carr; Francine E McCutchan
Summary of track A: basic science.
AIDS (London, England) 1996;10 Suppl 3():S85-106.
1996: John R Mascola; Mark K Louder; S R Surman; Thomas C VanCott; XIAOFANG YU; J Bradac; Kevin R Porter; Kenrad E Nelson; M Girard; John G McNeil; Francine E McCutchan; Deborah L Birx; Donald S. Burke
Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay.
AIDS research and human retroviruses 1996;12(14):1319-28.
1996: Jerome H Kim; R J McLinden; Joseph Mosca; Donald S. Burke; R N Boswell; Deborah L Birx; Robert R Redfield
Transcriptional effects of superinfection in HIV chronically infected T cells: studies in dually infected clones.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(4):329-42.
1996: Nelson L Michael; K E Davis; Lawrence D Loomis-Price; Thomas C VanCott; Donald S. Burke; Robert R Redfield; Deborah L Birx
V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patients.
AIDS (London, England) 1996;10(2):121-9.
1996: S Ratto; KV Sitz; A M Scherer; L D Loomis; J H Cox; Robert R Redfield; Deborah L Birx
CD4+ T-lymphocyte lines developed from HIV-1-seropositive patients recognize different epitopes within the V3 loop.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(2):128-36.
1995: Thomas C VanCott; V R Polonis; L D Loomis; Nelson L Michael; P L Nara; Deborah L Birx
Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.
AIDS research and human retroviruses 1995;11(11):1379-91.
1995: Nelson L Michael; G Chang; L A d'Arcy; C J Tseng; Deborah L Birx; Haynes W Sheppard
Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.
Journal of virology 1995;69(11):6758-69.
1995: Thomas C VanCott; F R Bethke; Donald S. Burke; Robert R Redfield; Deborah L Birx
Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccines.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(8):4100-10.
1995: J D Fontenot; Thomas C VanCott; Bharat Parekh; Chou-Pong Pau; J Richard George; Deborah L Birx; Susan Zolla-Pazner; Miroslaw K Gorny; J M Gatewood
Presentation of HIV V3 loop epitopes for enhanced antigenicity, immunogenicity and diagnostic potential.
AIDS (London, England) 1995;9(10):1121-9.
1995: L D Loomis; C D Deal; K S Kersey; Donald S. Burke; Robert R Redfield; Deborah L Birx
Humoral responses to linear epitopes on the HIV-1 envelope in seropositive volunteers after vaccine therapy with rgp160.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10(1):13-26.
1995: Nelson L Michael; G Chang; L A d'Arcy; Philip K Ehrenberg; R Mariani; M P Busch; Deborah L Birx; David H Schwartz
Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus.
Journal of virology 1995;69(7):4228-36.
1995: Thomas C VanCott; S C Veit; V Kalyanaraman; P Earl; Deborah L Birx
Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen.
Journal of immunological methods 1995;183(1):103-17.
1995: S Ratto; KV Sitz; A M Scherer; F Manca; L D Loomis; J H Cox; Robert R Redfield; Deborah L Birx
Establishment and characterization of human immunodeficiency virus type 1 (HIV-1) envelope-specific CD4+ T lymphocyte lines from HIV-1-seropositive patients.
The Journal of infectious diseases 1995;171(6):1420-30.
1995: Nelson L Michael; T Mo; A Merzouki; M O'Shaughnessy; C Oster; Donald S. Burke; Robert R Redfield; Deborah L Birx; Sharon Cassol
Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort.
Journal of virology 1995;69(3):1868-77.
1994: Jerome H Kim; S Ratto; KV Sitz; Joseph Mosca; R J McLinden; K L Tencer; Maryanne Vahey; DC St Louis; Deborah L Birx; Robert R Redfield
Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cells.
Human gene therapy 1994;5(12):1457-66.
1994: Thomas C VanCott; F R Bethke; V Kalyanaraman; Donald S. Burke; Robert R Redfield; Deborah L Birx
Preferential antibody recognition of structurally distinct HIV-1 gp120 molecules.
Journal of acquired immune deficiency syndromes 1994;7(11):1103-15.
1994: R Biselli; L D Loomis; Valerio Del Bono; Donald S. Burke; Robert R Redfield; Deborah L Birx
Immunization of HIV-infected patients with rgp160: modulation of anti-rgp120 antibody spectrotype.
Journal of acquired immune deficiency syndromes 1994;7(10):1016-24.
1994: Thomas C VanCott; F R Bethke; V R Polonis; Miroslaw K Gorny; Susan Zolla-Pazner; Robert R Redfield; Deborah L Birx
Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(1):449-59.
1994: Maryanne Vahey; Deborah L Birx; Nelson L Michael; Donald S. Burke; Robert R Redfield
Assessment of gag DNA and genomic RNA in peripheral blood mononuclear cells in HIV-infected patients receiving intervention with a recombinant gp 160 subunit vaccine in a phase I study.
AIDS research and human retroviruses 1994;10(6):649-54.
1994: P R Burnett; Thomas C VanCott; V R Polonis; Robert R Redfield; Deborah L Birx
Serum IgA-mediated neutralization of HIV type 1.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(9):4642-8.
1993: Deborah L Birx; Mark G Lewis; Maryanne Vahey; K Tencer; P M Zack; C R Brown; Peter B Jahrling; G Tosato; Donald S. Burke; Robert R Redfield
Association of interleukin-6 in the pathogenesis of acutely fatal SIVsmm/PBj-14 in pigtailed macaques.
AIDS research and human retroviruses 1993;9(11):1123-9.
1993: Deborah L Birx; J Brundage; K Larson; R Engler; L Smith; E Squire; G Carpenter; M Sullivan; J Rhoads; C Oster
The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. Military Medical Consortium for Applied Retroviral Research.
Journal of acquired immune deficiency syndromes 1993;6(11):1248-57.
1993: D R Lucey; Thomas C VanCott; L D Loomis; F R Bethke; Craig W Hendrix; G P Melcher; Robert R Redfield; Deborah L Birx
Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop).
Journal of acquired immune deficiency syndromes 1993;6(9):994-1001.
1993: M Levi; U Rudén; Deborah L Birx; L Loomis; Robert R Redfield; K Lövgren; Lennart Akerblom; Eric Sandström; Britta Wahren
Effects of adjuvants and multiple antigen peptides on humoral and cellular immune responses to gp160 of HIV-1.
Journal of acquired immune deficiency syndromes 1993;6(8):855-64.
1992: Robert R Redfield; Deborah L Birx; N Ketter; V Polonis; S Johnson; Charles Davis; G Smith; C Oster; Donald S. Burke
Vaccine therapy using rgp 160 in early HIV infection.
AIDS research and human retroviruses 1992;8(8):1333.
1992: Robert R Redfield; Deborah L Birx
HIV-specific vaccine therapy: concepts, status, and future directions.
AIDS research and human retroviruses 1992;8(6):1051-8.
1992: Thomas C VanCott; L D Loomis; Robert R Redfield; Deborah L Birx
Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1.
Journal of immunological methods 1992;146(2):163-76.
1991: Robert R Redfield; Deborah L Birx; N Ketter; E Tramont; V Polonis; Charles Davis; J F Brundage; G Smith; S Johnson; A Fowler
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research.
The New England journal of medicine 1991;324(24):1677-84.
1991: Deborah L Birx; J L Rhoads; J C Wright; Donald S. Burke; Robert R Redfield
Immunologic parameters in early-stage HIV-seropositive subjects associated with vaccine responsiveness.
Journal of acquired immune deficiency syndromes 1991;4(2):188-96.
1991: Deborah L Birx; Robert R Redfield
HIV vaccine therapy.
International journal of immunopharmacology 1991;13 Suppl 1():129-32.
1991: J L Rhoads; Deborah L Birx; D C Wright; John F Brundage; B L Brandt; Robert R Redfield; Donald S. Burke
Safety and immunogenicity of multiple conventional immunizations administered during early HIV infection.
Journal of acquired immune deficiency syndromes 1991;4(7):724-31.
1990: Deborah L Birx; Robert R Redfield; K Tencer; A Fowler; Donald S. Burke; G Tosato
Induction of interleukin-6 during human immunodeficiency virus infection.
Blood 1990;76(11):2303-10.